Produced by Araxis Merge on 7/9/2017 11:01:41 PM Eastern Daylight Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
# | Location | File | Last Modified |
---|---|---|---|
1 | PPS_N_3.0_Iter2_Build_360.zip\Unredacted\PS_PPS_ui\src\test\resources\messages | optionalSpecificDoseCheckResponse.xml | Fri Jun 30 19:05:24 2017 UTC |
2 | PPS_N_3.0_Iter2_Build_360.zip\Unredacted\PS_PPS_ui\src\test\resources\messages | optionalSpecificDoseCheckResponse.xml | Sun Jul 2 20:49:59 2017 UTC |
Description | Between Files 1 and 2 |
|
---|---|---|
Text Blocks | Lines | |
Unchanged | 2 | 480 |
Changed | 1 | 2 |
Inserted | 0 | 0 |
Removed | 0 | 0 |
Whitespace | |
---|---|
Character case | Differences in character case are significant |
Line endings | Differences in line endings (CR and LF characters) are ignored |
CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
1 | <?xml | |
2 | version="1 .0" | |
3 | encoding=" UTF-8" | |
4 | ?> | |
5 | <PEPSRespo nse | |
6 | ||
7 | xsi:schema Location=" gov/va/med /pharmacy/ peps/exter nal/common /preencaps ulation/vo /drug/chec k/response drugCheck SchemaOutp ut.xsd" | |
8 | ||
9 | xmlns:xsi= "http://ww w.w3.org/2 001/XMLSch ema-instan ce" | |
10 | xmlns="gov /va/med/ph armacy/pep s/external /common/pr eencapsula tion/vo/dr ug/check/r esponse" | |
11 | > | |
12 | ||
13 | <Header> | |
14 | ||
15 | <Time | |
16 | value="084 5" | |
17 | /> | |
18 | ||
19 | <MServer | |
20 | namespace= "VISTA" | |
21 | uci="text" | |
22 | ip=" IP " | |
23 | ||
24 | serverName ="Server N ame" | |
25 | stationNum ber="45" | |
26 | /> | |
27 | ||
28 | <MUser | |
29 | userName=" user" | |
30 | duz="88660 079" | |
31 | jobNumber= "365" | |
32 | /> | |
33 | ||
34 | <PEPSVersi on | |
35 | difIssueDa te="200810 20" | |
36 | difBuildVe rsion="6" | |
37 | difDbVersi on="3.2" | |
38 | /> | |
39 | ||
40 | </Header> | |
41 | ||
42 | <Body> | |
43 | ||
44 | <drugCheck > | |
45 | ||
46 | <drugDoseC hecks> | |
47 | ||
48 | <drugDoseC heck> | |
49 | ||
50 | <message> | |
51 | ||
52 | <drug | |
53 | orderNumbe r="Z;4;PRO SPECTIVE" | |
54 | ien="4444" | |
55 | ||
56 | drugName=" Advil" | |
57 | gcnSeqNo=" 16579" | |
58 | /> | |
59 | ||
60 | <severity> | |
61 | Informatio n | |
62 | </severity > | |
63 | ||
64 | <type> | |
65 | RenalImpai rment | |
66 | </type> | |
67 | ||
68 | <drugName> | |
69 | Advil | |
70 | </drugName > | |
71 | ||
72 | <text> | |
73 | Renal func tion is im portant in this drug 's elimina tion. Dosi ng adjustm ent should be consid ered in pa tients wit h an estim ated creat inine clea rance at o r below 10 ML/MIN. | |
74 | </text> | |
75 | ||
76 | </message> | |
77 | ||
78 | <message> | |
79 | ||
80 | <drug | |
81 | orderNumbe r="Z;4;PRO SPECTIVE" | |
82 | ien="4444" | |
83 | ||
84 | drugName=" Advil" | |
85 | gcnSeqNo=" 16579" | |
86 | /> | |
87 | ||
88 | <severity> | |
89 | Informatio n | |
90 | </severity > | |
91 | ||
92 | <type> | |
93 | HepaticImp airment | |
94 | </type> | |
95 | ||
96 | <drugName> | |
97 | Advil | |
98 | </drugName > | |
99 | ||
100 | <text> | |
101 | Hepatic fu nction is important in this dr ug's metab olism. Dos ing adjust ment shoul d be consi dered in p atients wi th signifi cant hepat ic impairm ent. | |
102 | </text> | |
103 | ||
104 | </message> | |
105 | ||
106 | <drug | |
107 | orderNumbe r="Z;4;PRO SPECTIVE" | |
108 | ien="4444" | |
109 | ||
110 | drugName=" Advil" | |
111 | gcnSeqNo=" 16579" | |
112 | /> | |
113 | ||
114 | <singleDos eStatus> | |
115 | Passed | |
116 | </singleDo seStatus> | |
117 | ||
118 | <singleDos eStatusCod e> | |
119 | 1 | |
120 | </singleDo seStatusCo de> | |
121 | ||
122 | <singleDos eMessage> | |
123 | </singleDo seMessage> | |
124 | ||
125 | <singleDos eMax> | |
126 | 80 MG | |
127 | </singleDo seMax> | |
128 | ||
129 | <rangeDose Status> | |
130 | BelowRecom mended | |
131 | </rangeDos eStatus> | |
132 | ||
133 | <rangeDose StatusCode > | |
134 | 4 | |
135 | </rangeDos eStatusCod e> | |
136 | ||
137 | <rangeDose Message> | |
138 | Total dose amount of 2 MG/DAY is below t he dosing range of 5 MG/DAY to 80 MG/DAY . | |
139 | </rangeDos eMessage> | |
140 | ||
141 | <rangeDose Low> | |
142 | 5 MG/DAY | |
143 | </rangeDos eLow> | |
144 | ||
145 | <rangeDose High> | |
146 | 80 MG/DAY | |
147 | </rangeDos eHigh> | |
148 | ||
149 | <doseHigh> | |
150 | 80 | |
151 | </doseHigh > | |
152 | ||
153 | <doseHighU nit> | |
154 | MG/DAY | |
155 | </doseHigh Unit> | |
156 | ||
157 | <doseLow> | |
158 | 5 | |
159 | </doseLow> | |
160 | ||
161 | <doseLowUn it> | |
162 | MG/DAY | |
163 | </doseLowU nit> | |
164 | ||
165 | <doseFormH igh> | |
166 | 2 | |
167 | </doseForm High> | |
168 | ||
169 | <doseFormH ighUnit> | |
170 | EA/DAY | |
171 | </doseForm HighUnit> | |
172 | ||
173 | <doseFormL ow> | |
174 | 0.125 | |
175 | </doseForm Low> | |
176 | ||
177 | <doseFormL owUnit> | |
178 | EA/DAY | |
179 | </doseForm LowUnit> | |
180 | ||
181 | <doseRoute Descriptio n> | |
182 | ORAL | |
183 | </doseRout eDescripti on> | |
184 | ||
185 | <durationS tatus> | |
186 | UnableToCh eck | |
187 | </duration Status> | |
188 | ||
189 | <durationS tatusCode> | |
190 | 5 | |
191 | </duration StatusCode > | |
192 | ||
193 | <durationM essage> | |
194 | </duration Message> | |
195 | ||
196 | <frequency Status> | |
197 | Passed | |
198 | </frequenc yStatus> | |
199 | ||
200 | <frequency StatusCode > | |
201 | 1 | |
202 | </frequenc yStatusCod e> | |
203 | ||
204 | <frequency Message> | |
205 | </frequenc yMessage> | |
206 | ||
207 | <dailyDose Status> | |
208 | BelowRecom mended | |
209 | </dailyDos eStatus> | |
210 | ||
211 | <dailyDose StatusCode > | |
212 | 4 | |
213 | </dailyDos eStatusCod e> | |
214 | ||
215 | <dailyDose Message> | |
216 | Total dose amount of 2 MG/DAY is below t he dosing range of 5 MG/DAY to 80 MG/DAY . | |
217 | </dailyDos eMessage> | |
218 | ||
219 | <maxDailyD oseStatus> | |
220 | Passed | |
221 | </maxDaily DoseStatus > | |
222 | ||
223 | <maxDailyD oseStatusC ode> | |
224 | 1 | |
225 | </maxDaily DoseStatus Code> | |
226 | ||
227 | <maxDailyD oseMessage > | |
228 | </maxDaily DoseMessag e> | |
229 | ||
230 | <maxLifeti meDose> | |
231 | 0 | |
232 | </maxLifet imeDose> | |
233 | ||
234 | </drugDose Check> | |
235 | ||
236 | </drugDose Checks> | |
237 | ||
238 | </drugChec k> | |
239 | ||
240 | </Body> | |
241 | </PEPSResp onse> |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.